4BVG
CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH NATIVE ALKYLIMIDATE FORMED FROM ACETYL-LYSINE ACS2-PEPTIDE CRYSTALLIZED IN PRESENCE OF THE INHIBITOR EX-527
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | BESSY BEAMLINE 14.1 |
Synchrotron site | BESSY |
Beamline | 14.1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2012-03-21 |
Detector | MARMOSAIC 225 mm CCD |
Spacegroup name | C 2 2 21 |
Unit cell lengths | 78.023, 131.329, 76.508 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 38.180 - 2.500 |
R-factor | 0.1856 |
Rwork | 0.182 |
R-free | 0.24831 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3glt |
RMSD bond length | 0.015 |
RMSD bond angle | 1.936 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | REFMAC (5.7.0032) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 38.200 | 2.600 |
High resolution limit [Å] | 2.500 | 2.500 |
Rmerge | 0.070 | 0.520 |
Number of reflections | 12915 | |
<I/σ(I)> | 20.8 | 3.8 |
Completeness [%] | 92.4 | 93.9 |
Redundancy | 5.6 | 5.6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 5.5 | 293 | 0.2 M (NH4)2SO4, 0.1M BISTRIS PH 5.5, 21% PEG 3350 |